Amanote Research

Amanote Research

    RegisterSign In

Endogenous Opioids in the Etiology and Treatment of Multiple Sclerosis

doi 10.15586/codon.multiplesclerosis.2017.ch8
Full Text
Open PDF
Abstract

Available in full text

Date

November 14, 2017

Authors
IAN S. ZAGONPATRICIA J. MCLAUGHLIN
Publisher

Codon Publications


Related search

Vitamin D Role in Multiple Sclerosis Etiology and Therapy

Medicinski Casopis
Medicine
2018English

The Placebo Effect and Endogenous Opioids

Journal of the Royal Society of Medicine
Medicine
2000English

Chemotherapeutics in the Treatment of Multiple Sclerosis

Therapeutic Advances in Neurological Disorders
NeurologyPharmacology
2010English

Treatment of Multiple Sclerosis

Clinical Medicine and the Nervous System
1992English

Treatment Satisfaction in Multiple Sclerosis

International Journal of MS Care
NeurologySpecialized NursingAdvanced
2014English

Using Endogenous Saccades to Characterize Fatigue in Multiple Sclerosis

Multiple Sclerosis and Related Disorders
MedicineNeurology
2017English

Natalizumab Treatment in Multiple Sclerosis

Clinical Neurology
Neurology
2015English

Testosterone Treatment in Multiple Sclerosis

Archives of Neurology
2007English

Endogenous Opioids and Baroreflex Control in Humans

Hypertension
Internal Medicine
1983English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy